Skip to content

ADD & ADHD Health Center

Font Size

FDA OKs ADHD Drug Vyvanse for Adults

Vyvanse Already on the Market for Kids With Attention Deficit Hyperactivity Disorder
WebMD Health News
Reviewed by Louise Chang, MD

April 23, 2008 -- The FDA has approved the drug Vyvanse for the treatment of attention deficit hyperactivity disorder (ADHD) in adults, according to the drug company Shire, which makes Vyvanse.

Vyvanse, a stimulant drug, was first approved by the FDA in 2007 to treat ADHD symptoms in children ages 6-12.

Shire says the FDA approved Vyvanse for adult use based on a clinical trial of 414 adults ages 18-55 who took Vyvanse or a placebo pill for four weeks. Patients taking Vyvanse "experienced significant improvements in ADHD symptom control within one week of treatment with once-daily Vyvanse," says Shire.

All three doses of Vyvanse that were studied -- 30 milligrams, 50 milligrams, and 70 milligrams -- trumped the placebo; the most commonly reported adverse events were decreased appetite, difficulty in falling asleep, and dry mouth, notes Shire.

Today on WebMD

Post it notes
Symptoms and treatments.
Close up of eye
What's zapping your focus?
man driving car
How to manage your impulses.
contemplating woman
Learn to stop procrastinating.
concentration killers
Woman taking a vitamin or supplement
ADHD and Substance Abuse
Reduce Side Effects ADHD Medications

boy eating egg
smiling man
ADHD in Marriage and Romantic Relationships
Adult man lying awake in bed